Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Emerging Microbes & Infections|February 15, 2021
Inflammation-related adverse reactions following vaccination potentially indicate a stronger immune responseChun-Lan Zhuang, Zhi-Jie Lin, Zhao-Feng Bi, et al.
Asia Pacific Journal of Clinical Nutrition|July 22, 2016
A survey of the enteral nutrition practices in patients with neurological disorders in the tertiary hospitals of ChinaYing-Ying Su, Dai-Quan Gao, Xiao-Yan Zeng, et al.
Human Vaccines & Immunotherapeutics|July 14, 2022
Safety and immunogenicity of an Escherichia coli-produced bivalent human papillomavirus type 6/11 vaccine: A dose-escalation, randomized, double-blind, placebo-controlled phase 1 trialZhao-Jun Mo, Zhao-Feng Bi, Wei Sheng, et al.
Science China. Life Sciences|June 25, 2019
Immunogenicity noninferiority study of 2 doses and 3 doses of an Escherichia coli-produced HPV bivalent vaccine in girls vs. 3 doses in young womenYue-Mei Hu, Meng Guo, Chang-Gui Li, et al.
The Lancet Regional Health. Western Pacific|June 7, 2023
Safety and immunogenicity of anKai Chu, Zhao-Feng Bi, Wei-Jin Huang, et al.
The Lancet Regional Health. Western Pacific|September 8, 2025
Immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil9 in Chinese women aged 18-26 years: three-year follow-up data from a randomised clinical trialGuo-Hua Zhong, Zhao-Feng Bi, Kai Chu, et al.
The European Respiratory Journal|May 21, 2020
Serology characteristics of SARS-CoV-2 infection after exposure and post-symptom onsetBin Lou, Ting-Dong Li, Shu-Fa Zheng, et al.
Infectious Diseases of Poverty|August 27, 2020
A five-compartment model of age-specific transmissibility of SARS-CoV-2Ze-Yu Zhao, Yuan-Zhao Zhu, Jing-Wen Xu, et al.
The Lancet. Infectious Diseases|July 20, 2023
Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18-26 years in China: a randomised blinded clinical trialFeng-Cai Zhu, Guo-Hua Zhong, Wei-Jin Huang, et al.
The Lancet Regional Health. Western Pacific|June 7, 2023
Safety and immunogenicity of a skin- and neuro-attenuated live vaccine for varicella: a randomized, double-blind, controlled, dose-escalation and age de-escalation phase 1 clinical trialZhao-Jun Mo, Shou-Jie Huang, Ling-Xian Qiu, et al.
Pageof 8